Published Online
on March 6, 2008

A more recent version of this article appeared on May 1, 2008

This Article Full Text (PDF) All Versions of this Article: 39/5/1406    most recent STROKEAHA.107.506832v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lip, G. Y.H. Search for Related Content PubMed PubMed Citation Articles by Lip, G. Y.H. Related Collections Other Stroke Treatment - Medical Related Article

The Balance Between Stroke Prevention and Bleeding Risk in Atrial Fibrillation. A Delicate Balance Revisited

Gregory Y.H. Lip MD^*

From the University Department of Medicine, City Hospital, Birmingham, England, UK.

^* To whom correspondence should be addressed. E-mail: g.y.h.lip{at}bham.ac.uk.

Key words: atrial fibrillation • bleeding anticoagulation • stroke • thromboembolism

Related Article:

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)

Jeff S. Healey, Robert G. Hart, Janice Pogue, Marc A. Pfeffer, Stefan H. Hohnloser, Raffaele De Caterina, Greg Flaker, Salim Yusuf, and Stuart J. Connolly
Stroke 2008 39: 1482-1486. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				D. Poli, E. Antonucci, E. Grifoni, R. Abbate, G. F. Gensini, and D. Prisco Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J. Am. Coll. Cardiol., September 8, 2009; 54(11): 999 - 1002. [Abstract] [Full Text] [PDF]